Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155




 Company News
Aegerion (AEGR) Announces Presentation At The Jefferies and Co. 2015 Healthcare Conference 5/28/2015 7:15:40 AM
Aegerion (AEGR)'s Lomitapide Achieves Primary Endpoint in Phase III Study for HoFH Patients 5/26/2015 5:35:17 AM
BREAKING: Aegerion (AEGR) CFO Leaving for New Job, Not Forced Out, Says Spokesperson 5/15/2015 12:29:46 PM
Aegerion (AEGR) CFO Is Out, As Embattled Firm Faces Possible Coup 5/15/2015 5:57:30 AM
Aegerion (AEGR) Grants Stock Options Under Inducement Program 5/11/2015 2:39:12 PM
Aegerion (AEGR) Announces First Quarter 2015 Financial Results 5/4/2015 2:36:50 PM
Aegerion (AEGR) To Announce First Quarter 2015 Financial Results On Monday, May 4 4/22/2015 8:24:16 AM
Aegerion (AEGR) Grants Stock Options Under Inducement Program 4/15/2015 7:43:19 AM
Jorge Plutzky, M.D., Appointed To Aegerion (AEGR)'s Board Of Directors 4/9/2015 7:48:27 AM
Aegerion (AEGR) Reaches Agreement With Sarissa Capital 3/30/2015 6:49:23 AM